Pharma-Bio Serv, Inc.
Pharma-Bio Serv, Inc.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-04-30 | 2026-01-31 | 2025-10-31 | 2025-07-31 | 2025-04-30 | 2025-01-31 | 2024-10-31 | 2024-07-31 | 2024-04-30 | 2024-01-31 | 2023-10-31 | 2023-07-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 2 | 6 | 3 | 4 | 2 | 7 | 7 | 7 | 4 | 6 | 10 | 3 | |||||
Assets | |||||||||||||||||
Marketable Securities Current | 7 | 5 | 7 | 7 | 8 | 5 | 6 | 6 | 10 | 9 | 5 | 12 | |||||
Accounts Receivable Net Current | 3 | 3 | 2 | 2 | 3 | 3 | 3 | 3 | 3 | 2 | 4 | 5 | |||||
Prepaid Expense And Other Assets | - | - | 0 | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 1 | |||||
Prepaid Expense And Other Assets Current | 0 | 0 | - | 0 | 0 | - | - | - | - | - | - | - | |||||
Assets Current | 11 | 13 | 13 | 13 | 13 | 16 | 16 | 16 | 17 | 19 | 19 | 20 | |||||
Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Operating Lease Right Of Use Asset | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Other Assets Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Assets | 11 | 14 | 14 | 14 | 14 | 16 | 16 | 16 | 17 | 19 | 20 | 20 | |||||
Liabilities Current | |||||||||||||||||
Liabilities And Stockhold… | |||||||||||||||||
Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Accounts Payable And Accrued Liabilities Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | |||||
Convertible Notes Payable Current | - | - | - | - | - | - | - | - | - | 2 | - | - | |||||
Policyholder Dividends Payable | - | - | - | - | - | 2 | - | - | - | - | - | - | |||||
Dividends Payable Current | - | 2 | - | - | - | - | - | - | - | - | - | - | |||||
Accrued Income Taxes Current | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Liabilities Current | 1 | 3 | 2 | 2 | 2 | 3 | 2 | 2 | 2 | 4 | 2 | 2 | |||||
Accrued Income Taxes Noncurrent | - | - | - | 0 | 0 | - | - | - | - | - | - | 1 | |||||
Taxes Payable Current | - | - | 0 | - | - | - | 1 | - | - | - | - | - | |||||
Operating Lease Liability Noncurrent | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Liabilities | 1 | 3 | 2 | 2 | 2 | 4 | 3 | 3 | 3 | 5 | 4 | 4 | |||||
Stockholders Equity | |||||||||||||||||
Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Commitments And Contingen… | |||||||||||||||||
Additional Paid In Capital | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | |||||
Retained Earnings Accumulated Deficit | 9 | 9 | 11 | 11 | 11 | 11 | 12 | 12 | 13 | 13 | 15 | 15 | |||||
Accumulated Other Comprehensive Income Loss Net Of… | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Stockholders Equity Before Treasury Stock | 11 | 11 | 12 | - | - | 13 | 14 | 14 | 14 | 15 | 17 | 17 | |||||
Treasury Stock Value | - | - | -1 | - | - | -1 | -1 | -1 | -1 | -1 | -1 | - | |||||
Treasury Stock Common Value | -1 | -1 | - | -1 | -1 | - | - | - | - | - | - | -1 | |||||
Stockholders Equity | 10 | 10 | 12 | 12 | 12 | 12 | 14 | 14 | 14 | 14 | 16 | 16 | |||||
Liabilities And Stockholders Equity | 11 | 14 | 14 | 14 | 14 | 16 | 16 | 16 | 17 | 19 | 20 | 20 | |||||
Preferred Stock Par Or Stated Value Per Share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Preferred Stock Shares Authorized | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | |||||
Preferred Stock Shares Issued | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Par Or Stated Value Per Share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Shares Authorized | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | |||||
Common Stock Shares Issued | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | |||||
Shares Outstanding | 23 | 23 | 23 | 23 | 23 | 23 | 23 | 23 | 23 | 23 | 23 | 23 | |||||
Treasury Stock Common Shares | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 2.08% | 20.83% | 10.42% | 0.00% | - | - | - | - | - | - | - | - |
| 2025 | -9.09% | -9.09% | -12.73% | 22.45% | 22.45% | 22.45% | 5.26% | -5.26% | -5.26% | 7.41% | 1.83% | 6.08% |
| 2024 | 2.38% | -10.71% | -17.86% | 22.64% | 22.64% | 15.09% | -1.59% | -6.35% | -20.63% | -1.69% | -22.52% | -3.15% |
| 2023 | - | - | - | - | - | - | -2.17% | -6.52% | -7.61% | -10.28% | -25.23% | -25.23% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Metrics | 2026-04-30 | 2026-01-31 | 2025-10-31 | 2025-07-31 | 2025-04-30 | 2025-01-31 | 2024-10-31 | 2024-07-31 | 2024-04-30 | 2024-01-31 | 2023-10-31 | 2023-07-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Metric history beyond 3 years is for subscribers only. Unlock 17+ years of history across 90+ calculated metrics Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 10.80 | 4.03 | 7.70 | 7.93 | 7.54 | 4.54 | 8.32 | 8.39 | 7.52 | 5.10 | 9.01 | 8.05 | |||||
| Quick Ratio | 10.71 | 3.99 | 7.70 | 7.68 | 7.35 | 4.54 | 8.32 | 8.39 | 7.52 | 5.10 | 9.01 | 8.05 | |||||
| Working Capital | 10.24M | 10.01M | 11.65M | 11.50M | 11.64M | 12.11M | 13.81M | 14.04M | 14.32M | 15.10M | 17.25M | 17.28M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | 0.10 | 0.32 | 0.15 | 0.14 | 0.15 | 0.34 | 0.19 | 0.19 | 0.21 | 0.36 | 0.23 | 0.25 | |||||
| Interest Coverage TTM | - | - | - | - | - | - | - | - | - | - | 8.30 | 9.94 | |||||
| Debt Ratio | 0.09 | 0.24 | 0.13 | 0.12 | 0.13 | 0.25 | 0.16 | 0.16 | 0.18 | 0.26 | 0.19 | 0.20 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.72 | 0.60 | 0.60 | 0.61 | 0.63 | 0.54 | 0.53 | 0.59 | 0.71 | 0.75 | 0.84 | 0.89 | |||||
| Days Sales Outstanding TTM | 108.32 | 110.36 | 98.77 | 91.69 | 100.32 | 96.75 | 123.82 | 122.47 | 107.86 | 81.28 | 95.93 | 95.56 | |||||
| Receivables Turnover TTM | 3.37 | 3.31 | 3.70 | 3.98 | 3.64 | 3.77 | 2.95 | 2.98 | 3.38 | 4.49 | 3.81 | 3.82 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | 0.00 | -0.00 | -0.00 | -0.00 | -0.01 | -0.02 | -0.03 | -0.04 | -0.00 | 0.03 | 0.06 | 0.07 | |||||
| Free Cash Flow Per Share TTM | -0.01 | -0.01 | -0.01 | -0.03 | -0.06 | -0.08 | -0.03 | -0.01 | 0.06 | 0.08 | 0.08 | 0.08 | |||||
| Dividend Per Share TTM | 0.15 | 0.15 | 0.22 | 0.23 | 0.22 | 0.22 | 0.22 | 0.15 | 0.15 | 0.15 | 0.08 | 0.08 | |||||
Margin Metrics | |||||||||||||||||
| Gross Profit Margin TTM | 32.35% | 32.46% | 32.33% | 31.44% | 30.59% | 28.63% | 26.46% | 25.24% | 28.10% | 28.85% | 29.84% | 29.11% | |||||
| Operating Profit Margin TTM | -4.36% | -7.25% | -7.08% | -7.17% | -7.54% | -9.81% | -13.54% | -11.00% | -2.65% | 2.32% | 6.58% | 7.43% | |||||
| Net Profit Margin TTM | 0.67% | -0.86% | -1.12% | -0.92% | -1.96% | -5.19% | -8.18% | -7.80% | -0.04% | 4.05% | 7.72% | 8.50% | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | -5.49% | -8.08% | -5.34% | -14.75% | -25.46% | -36.50% | -43.99% | -40.20% | -28.99% | -18.80% | -12.48% | -11.50% | |||||
| Net Income Growth (1Y) | -132.50% | -84.72% | -87.08% | -89.98% | 3,376.55% | -181.30% | -159.35% | -154.93% | -100.42% | -45.65% | 30.15% | -137.89% | |||||
| EPS Growth (1Y) | -132.55% | -84.69% | -87.07% | -89.97% | 3,380.64% | -181.31% | -159.36% | -154.94% | -100.42% | -45.69% | 30.33% | -137.87% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | 186.21 | -154.93 | -107.66 | -144.90 | -48.67 | -21.11 | -13.08 | -13.56 | -2,384.70 | 27.46 | 10.56 | 11.38 | |||||
| P/B TTM | 1.10 | 1.15 | 0.91 | 1.02 | 0.76 | 0.88 | 0.74 | 0.83 | 0.93 | 1.19 | 0.86 | 1.08 | |||||
| P/S TTM | 1.26 | 1.34 | 1.20 | 1.33 | 0.96 | 1.10 | 1.07 | 1.06 | 1.00 | 1.11 | 0.82 | 0.97 | |||||
| Market Cap | 11.45M | 11.80M | 10.82M | 12.21M | 9.21M | 10.52M | 10.17M | 11.40M | 12.98M | 16.84M | 13.84M | 17.41M | |||||
| Enterprise Value | 9.66M | 6.03M | 7.44M | 8.25M | 7.12M | 3.21M | 3.41M | 4.88M | 9.47M | 12.15M | 3.39M | 14.55M | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | -246.38K | -184.59K | -221.53K | -579.44K | -1.49M | -1.88M | -726.44K | -341.00K | 1.29M | 1.74M | 1.88M | 1.82M | |||||
| Net Debt | -1.79M | -5.76M | -3.38M | -3.96M | -2.09M | -7.31M | -6.77M | -6.52M | -3.51M | -4.69M | -10.45M | -2.87M | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
| NCAV | |||||||||||||||||
| NCAV Per Share TTM | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| PEG Ratio | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| EV Revenue TTM | |||||||||||||||||
| EV FCF TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Pharma-Bio Serv, Inc. (PBSV) — SEC Financial Statements & Analysis
Pharma-Bio Serv, Inc. (PBSV) is a services-management consulting services company. Pharma-Bio Serv, Inc. trades on OTC as: PBSV. Based on its latest SEC filing (Form 10-Q, period ending 2026-04-30), Pharma-Bio Serv, Inc. reported a -5.49% year-over-year revenue growth, a Gross Profit Margin of 32.35% (TTM), a Debt-to-Equity ratio of 0.10x, a Price-to-Sales (P/S) ratio of 1.26x (TTM), a Price-to-Book (P/B) ratio of 1.10x (TTM), at a market cap of $11.45M. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- -5.49%
- Gross Profit Margin TTM
- 32.35%
- Debt To Equity
- 0.10x
- P/S TTM
- 1.26x
- P/B TTM
- 1.10x
- Market Cap
- $11.45M
Data as of 2026-04-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Pharma-Bio Serv, Inc. in?
Pharma-Bio Serv, Inc. (PBSV) operates in the Services-Management Consulting Services industry.
What is PBSV's market cap?
Pharma-Bio Serv, Inc. (PBSV) has a market capitalization of $11.45M as of 2026-04-30.
What is PBSV's P/E ratio?
Pharma-Bio Serv, Inc. (PBSV)'s trailing twelve month P/E ratio is 186.21x as of 2026-04-30.
What exchange does PBSV trade on?
Pharma-Bio Serv, Inc. (PBSV) trades on the OTC.